Hagelskjaer L H
Danish-Bangladesh Leprosy Mission, District Nilphamari.
Eur J Clin Microbiol Infect Dis. 1994 Dec;13(12):1069-74. doi: 10.1007/BF02111831.
Systemic strongyloidiasis is a rare but serious complication of intestinal strongyloidiasis. The condition occurs mainly in immunosuppressed patients and has a significant mortality rate. A case of systemic strongyloidiasis is described in a patient who received systemic steroid treatment, and a short review of the literature is given. The increased use of immunosuppressive and cytotoxic treatment necessitates increased awareness of this infection. HIV-infection, however, does not appear to increase the risk of developing systemic strongyloidiasis. Patients from endemic areas and travellers to such areas, even in the remote past, should be examined for strongyloidiasis before being given immunosuppressive treatment. Awareness of the possibility of systemic strongyloidiasis is essential if such a patient develops gastrointestinal or pulmonary symptoms or has repeated episodes of unexplained gram-negative infections while undergoing immunosuppressive treatment.
系统性类圆线虫病是肠道类圆线虫病一种罕见但严重的并发症。该病症主要发生在免疫抑制患者中，死亡率较高。本文描述了一例接受全身类固醇治疗的系统性类圆线虫病患者，并对相关文献进行了简要回顾。免疫抑制和细胞毒性治疗的使用增加，使得人们有必要提高对这种感染的认识。然而，HIV感染似乎并不会增加发生系统性类圆线虫病的风险。来自流行地区的患者以及前往这些地区的旅行者，即使是过去很久之前去过，在接受免疫抑制治疗前都应检查是否感染类圆线虫病。如果此类患者在接受免疫抑制治疗时出现胃肠道或肺部症状，或反复出现不明原因的革兰氏阴性菌感染，认识到发生系统性类圆线虫病的可能性至关重要。
